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Trigger factor, a ribosome-associated chaperone and peptidyl-prolyl cis-trans isomerase (PPIase), is essen-
tial for the secretion and maturation of the cysteine protease of the pathogenic gram-positive bacterium
Streptococcus pyogenes. In the absence of trigger factor, the nascent protease polypeptide is not targeted to the
secretory pathway. Some partial-function mutations restore targeting. However, the secreted protease does not
efficiently mature into an enzymatically active form, suggesting that trigger factor has an additional role in
protease biogenesis. Here, we show that, while not required for targeting, the PPIase activity of trigger factor
is essential for maturation of the protease following its secretion from the bacterial cell. Site-specific mutations
introduced into ropA, the gene which encodes trigger factor in S. pyogenes, produced mutant proteins deficient
in PPIase activity. When these mutant alleles were used to replace the wild-type gene on the streptococcal
chromosome, analysis of protease biogenesis revealed that, although the protease was secreted normally, it did
not efficiently mature to an active form. Furthermore, mutation of a single proline residue in the protease pro-
domain suppressed the requirement for PPIase activity, suggesting that this residue is the target of trigger
factor. These data support a model in which trigger factor-mediated prolyl isomerization influences the con-
formation of the prodomain, which in turn directs the protease into one of several alternative folding pathways.
The folding of a protein into its native structure requires the
coordinated interaction of a network of accessory proteins
known as molecular chaperones. There has been considerable
progress in understanding how chaperones function to fold
proteins in the cytoplasm (for a review see reference 1); how-
ever, the mechanisms by which they contribute to the folding of
secreted proteins are poorly understood. An example of a
cytoplasmic chaperone is trigger factor, an enigmatic protein
that was originally identified in a cell-free secretion system as
a factor that was required to present the substrate precursor
protein proOmpA to the secretory apparatus in a transloca-
tion-competent form (5). However, subsequent studies sug-
gested that trigger factor was neither essential for secretion of
any known protein in Escherichia coli or Bacillus subtilis nor
essential for cell viability (4, 9, 14, 38). Trigger factor has many
remarkable properties: it associates with the ribosome, binds to
nascent polypeptides in vivo, and possesses peptidyl-prolyl cis-
trans isomerase (PPIase) activity (21, 23). Recent studies have
indicated that, while mutants lacking the gene for trigger factor
or for the chaperone DnaK are viable under normal growth
conditions, simultaneous mutation of both genes is lethal (8,
38). Thus, there is considerable evidence that trigger factor
plays an important role in protein synthesis; however, its func-
tion is far from understood.
A new model for understanding trigger factor function has
come from the observation that trigger factor is required for
the secretion and maturation of the cysteine protease of the
gram-positive bacterium Streptococcus pyogenes (group A
streptococcus) (26). As the causative agent of diseases, which
include pharyngitis (strep throat) and necrotizing fasciitis, S.
pyogenes is an important human pathogen, and the secreted
cysteine protease (also known as SpeB) may contribute to the
organism’s ability to cause disease (3, 24, 25). Interestingly,
trigger factor was shown to be required for two distinct steps
in the biogenesis of the active protease. First, while a trigger
factor mutant produced the protease polypeptide, the protease
was not secreted from the bacterial cell, suggesting that trigger
factor is required for targeting the protease to the secretory
pathway. Second, an in-frame deletion mutation that excised
just the central region of trigger factor resulted in normal
levels of secretion of the protease zymogen. However, the
secreted protease from this mutant exhibited a multipartite
defect in maturation, including a kinetic defect in the autolo-
gous processing of the zymogen to the mature form, and the
mature protease had a catalytic defect (26). These data indi-
cate that, while this mutant form of trigger factor is competent
for targeting the protease, the central domain has activity
which influences the maturation of the protease following its
translocation across the cellular membrane. Furthermore,
this activity is required in response to some specific feature
of the protease since streptococcal trigger factor mutants do
not exhibit a general defect in protein secretion and func-
tion (26).
Multiple roles for trigger factor in the biogenesis of the
streptococcal protease are consistent with the modular struc-
ture of trigger factor. Of the three distinct domains defined for
trigger factor, the N- and C-terminal domains have been shown
to interact with each other and are required for binding to
substrate polypeptides (41). In addition, the N-terminal 118
amino acids are required for binding to ribosomes (17). The
central domain has homology to the family of FK506-binding
PPIase proteins (13, 16, 35). This class of proteins can catalyze
the isomerization of the peptide bond preceding a prolyl res-
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idue, and the central domain of trigger factor can function
independently in vitro as an active PPIase (16, 35). Prolyl
isomerization can be a rate-limiting step in protein folding
(22), and multiple studies of in vitro folding reactions support
a role for PPIases in folding (for reviews, see references 12 and
31). However, since mutations of PPIases generally do not
affect folding in vivo (10), the function of PPIases in protein
synthesis is less clear. The refolding of denatured proteins in
vitro can be catalyzed by trigger factor (14, 18). However, it
appears that this refolding reaction is facilitated primarily
through the chaperone function of trigger factor, involving
binding to hydrophobic regions exposed in the partially folded
protein to prevent aggregation rather than promotion of prolyl
isomerization (18). Thus, the role of the PPIase activity of
trigger factor is not understood.
The PPIase domain was included in the region removed by
the large central deletion in trigger factor that was analyzed for
S. pyogenes (26). Since the resulting mutant secreted a defec-
tive protease, these data support a model in which the PPIase
activity of trigger factor introduces essential information into
the nascent polypeptide prior to its secretion. Furthermore,
this model suggests that the molecular nature of this informa-
tion involves prolyl isomerization. However, it is possible that,
besides altering PPIase activity, the large deletion introduced
into the S. pyogenes trigger factor may have altered its confor-
mation, stability, and possible interdomain interactions. Thus,
a specific requirement for PPIase activity remains to be deter-
mined. The model also predicts that there is at least one prolyl
residue in the protease polypeptide whose conformation is
critical for maturation. If correct, this would provide a novel
model for understanding the contribution of prolyl isomeriza-
tion to protein folding in vivo.
In the present study, analysis of specific RopA mutants pro-
vided evidence to support an essential role for the PPIase
activity of trigger factor in protease maturation. Data to im-
plicate the isomerization state of a single prolyl residue in
directing the protease polypeptide into a productive or non-
productive maturation pathway are also presented. The loca-
tion of this residue in the protease prodomain suggests a model
in which prolyl isomerization influences the conformation of
the prodomain, which in turn directs the protease into one of
several alternative folding pathways.
MATERIALS AND METHODS
Bacterial strains. Molecular cloning experiments utilized E. coli DH5
(Gibco-BRL), and E. coli strain BL21(DE3) (36) was used for protein expres-
sion. Strain HSC130 contains ropA from wild-type S. pyogenes strain HSC5 with
an in-frame deletion of the region encoding residues 83 to 297 (ropA82-297) (26).
The construction of additional HSC5 mutants is described below. Routine cul-
ture of S. pyogenes strains utilized Todd-Hewitt medium (BBL) supplemented
with 0.2% yeast extract (Difco). When appropriate, antibiotics were added to
media at the following concentrations: kanamycin, 50 g/ml for E. coli and 500
g/ml for S. pyogenes; erythromycin, 750 g/ml for E. coli and 1 g/ml for S.
pyogenes; ampicillin, 100 g/ml for E. coli. All mutations in S. pyogenes were
stably maintained to the extent that culture for all functional assays did not
require the addition of antibiotics.
Plasmid construction. Plasmids for expression of trigger factor were based on
the expression vector pET24D (Novagen) and were constructed as follows.
Oligonucleotide primers startNcoI (AATGA CTCCA TGGCT ACATC ATTTG
AAAAC TTTCG ATG) and endXhoI (CCTTA ATACT CGAGC TTAAC
GCTTG CTGTG CTTGT AATCA C) were used to amplify ropA by PCR from
the plasmid pBL40 (see below). The resulting DNA fragment was inserted
between the NcoI and XhoI sites of pET24D by using the NcoI and XhoI sites
embedded in the primer sequences (underlined). The same strategy was used to
construct expression plasmids for each of the ropA alleles engineered to encode
a substitution of an alanine residue at selected positions (see below). The fidelity
of the resulting plasmids, pROP4 (wild type), pROP5 (ropAD180A), pROP6
(ropAF200A), and pROP7 (ropAF235A), was confirmed by determination of their
DNA sequences. Plasmids were constructed so as to place six-His affinity tags at
the carboxy termini of the expressed RopA proteins.
Purification of recombinant RopA. Plasmids were introduced into E. coli
expression strain BL21(DE3), and cultures for expression were prepared by
inoculation of 500 ml of Luria-Bertani medium supplemented with ampicillin
with growth from an overnight cultures to an optical density at 600 nm (OD600)
of 0.05. Cultures were incubated at 37°C with agitation (250 rpm) until an OD600
of 0.6 was reached, at which time isopropyl--D-thiogalactopyranoside (IPTG)
was added to a final concentration of 0.2 mM. Following an additional 3-h
incubation, cultures were harvested by centrifugation (10 min, 6,000  g, 4°C)
and resuspended in 1 ml of a nondenaturing lysis buffer (50 mM NaH2PO4 [pH
8.0], 300 mM NaCl, 10 mM imidazole, 1 mg of lysozyme/ml). After incubation on
ice for 30 min, bacteria were lysed by sonication (three pulses, 10 s each; model
185; Branson) with a microprobe at the highest-power setting. Debris was re-
moved by centrifugation (16,000  g, 20 min, 4°C), and the six-His-tagged
proteins were purified from the supernatant fluids by chromatography over a
nickel affinity resin (Ni-nitrilotriacetic acid) according the recommendations of
the manufacturer (Qiagen). Purity of preparations was assessed by sodium do-
decyl sulfate-polyacrylamide gel electrophoresis and staining with Coomassie
brilliant blue and was consistently greater than 95%. Protein concentrations were
determined by a bicinchoninic acid assay (Sigma).
Prolyl-isomerase activity assays. The presence of PPIase activity was deter-
mined by a protease coupling assay described by Fischer et al. (11). This assay
measures the conformation-specific cleavage of succinyl-Ala-Ala-Pro-Phe-4-
nitroanilide (Bachem) by -chymotrypsin (Sigma), which occurs only when the
substrate is in the trans conformation. The substrate exists in an equilibrium such
that at pH 7.8 approximately 20% is in the cis conformation, and the rate of
conversion of this fraction of substrate to a cleavable form in the presence or
absence of PPIase is determined. A stock solution of substrate (10 mg/ml) was
prepared in dimethyl sulfoxide and was diluted in reaction buffer (0.035 M
HEPES, pH 7.8) containing -chymotrypsin (0.5 mg/ml) and 1.0 M PPIase. The
PPIases included RopA, mutant RopAs, and a well-characterized PPIase, re-
combinant human FK-binding protein (Sigma). For kinetic analysis, the change
in absorbance at 390 nm over time was monitored at 10°C in a spectrophotom-
eter (Beckman DU-80). To measure solely the cis isomerization reaction without
PPIase-independent cleavage of the trans form, measurements were performed
following the initial cleavage of the trans population, as determined through
control reactions lacking PPIase activity. In the presence of PPIase, the kinetic
equation is kobs  ku  2(kcat/Km), where kobs is the first-order rate constant for
isomerization. The variable ku represents the first-order rate constant for un-
catalyzed isomerization, and kcat/Km is the catalytic activity. Thus, the enzyme-
catalyzed rate of isomerization (kcat/Km) can be calculated by the equation
kcat/Km  (kobs  ku)/2.
Construction of mutant streptococcal strains. Streptococcal strains that ex-
pressed RopA containing single amino acid substitutions for alanine at selected
residues were constructed by alteration of the single chromosomal copy of ropA
as follows. Oligonucleotide primers RopA 5	 XbaI (GCCAT AGTCA TCCGT
CTAGA AATGC) and RopA 3	 PstI (CTCAT ATCAC TGCAG CTTGA
CAAAT C) were used to amplify by PCR the region containing the ropA open
reading frame from the HSC5 chromosome; this region was then inserted be-
tween the XbaI and PstI sites of the E. coli/streptococcal shuttle vector pJRS233
(29) by using restriction sites embedded in the primer sequences (underlined).
The resulting plasmid (pBL40) was used as the template in an “inside-out” PCR
with primers RopA 180D/A up (CACCA TCAAC GGATC CAACA AAGTC
AATC) and RopA 180D/A down (TTGTT GGATC CGTTG ATGGT GTTGA
GTTTG CTGGC). Digestion of this amplification product with BamHI (sites
underlined), followed by religation, resulted in the replacement of the aspartate
codon with an alanine codon in ropA. The altered allele (ropAD180A) was used to
replace the resident chromosomal allele as described elsewhere (30), and re-
placement was confirmed by PCR amplification and digestion of amplified prod-
ucts with BamHI to probe for the unique BamHI site introduced at the mutated
codon. The resulting S. pyogenes mutant was designated RopA11. Additional
alterations were made by the same method. Primers pairs RopA 200F/A start
(ATTGT CCGGA TCCAA GTTCA AGAGA GAAG) and RopA 200F/A end
(AACTT GGATC CGGAC AATTT ATCCC AGGTG CTGAA) and RopA
235F/A start (TTAGC GGCGG ATCCT GCAAG ATCTT CTGC) and RopA
235F/A end (CTTGC AGGAT CCGCC GCTAA AGCTA TGACA AC) were
used for substitution of alanine for phenylalanine at positions 200 (ropA200F/A)
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and 235 (ropA235F/A), respectively. The resulting plasmids were designated
pROP2 and pROP3, and the corresponding mutant strains were designated
RopA12 and RopA13.
Streptococcal strains with the proline at residue 78 replaced by glycine were
constructed by alteration of the single chromosomal copy of speB as follows:
Oligonucleotide primers 1000speBBamHI (GAATG CCTAA TGGAT CCA
AC GGTTT CACAA) and SpeBstopBamHI (GGATA GCTTA ACTGC TG
GAT CCGCA TAGGG) were used to amplify by PCR the region containing the
speB open reading frame from the HSC5 chromosome; this region was then
inserted at the BamHI site of the E. coli/streptococcus shuttle vector pJRS233
(29) by using restriction sites embedded in the primer sequences (underlined).
The resulting plasmid (pSpeB112) was then used as the template in an inside-out
PCR with primers SpeBP78G start (CCTAG AATTT CTCCA GATCT TTTAT
CTCC) and SpeBP78Gend (GGAGA TAAAA GATCT GGAGA AATTC
TAGGA TAC). Digestion of this amplification product with BglII (sites under-
lined) followed by religation resulted in the replacement of the codon that codes
for proline with a glycine codon in speB. The altered allele (speBP78G) was used
to replace the resident chromosomal allele as described elsewhere (30), and
replacement was confirmed by PCR amplification and digestion of amplified
products with BglII to probe for the unique BglII site introduced at the mutated
codon. The resulting S. pyogenes mutant was designated SpeB14.
Measurement of protease activity. Expression of the protease was analyzed in
culture supernatants as follows. Cultures in C medium were initiated using cells
from overnight growth in C medium (26). The cells were washed in phosphate-
buffered saline (pH 7.4) to remove any residual protease. The initial OD600s of
cultures were adjusted to 0.01, samples were removed at various time points
during incubation at 37°C, and cells were removed by filtration (0.45-m-pore-
size sterile Acrodisc; Gelman Sciences). The resulting supernatant fluids were
diluted in fresh C medium to normalize for any differences in growth between
samples based on the OD600 of the culture at time of harvest. The presence
of the proprotein and processed forms of SpeB was determined in a Western
blot analysis as described previously (26). The proteolytic activities of super-
natants were quantitated by the method of Hauser and Schlievert (15), which
measures the increase in relative fluorescence generated by the proteolytic
cleavage of fluorescein isothiocyanate-casein (Sigma). The activity of unin-
oculated culture medium was used to derive background values, which were
typically undetectable under the conditions of this assay. To ensure that
all proteolytic activity was specifically the result of SpeB, the cysteine pro-
tease-specific inhibitor E-64 (final concentration, 10 mM; Sigma) was rou-




Construction of trigger factor mutations. The strategy for
determining whether the PPIase activity of trigger factor is
required for the maturation of the streptococcal protease in-
volved the construction of streptococcal strains which ex-
pressed a mutant trigger factor that was altered at a single
amino acid residue that specifically disrupted the PPIase ac-
tivity of the protein. As the first step in this analysis, the S.
pyogenes trigger factor (RopA) was expressed in E. coli with a
six-His affinity tag and purified to homogeneity by standard
methods (see Materials and Methods). Analysis of the result-
ing protein confirmed that it possessed an active PPIase activ-
ity for the synthetic substrate succinyl-Ala-Ala-Pro-Phe-4-
nitroanilide, as determined by the protease coupling assay of
Fischer et al. (11) (kcat/Km  54.1  5.3 mM
1 s1), that was
comparable to that of human FKBP (kcat/Km  66.3  4.1
mM1 s1), a well-studied member of the FK506 family of
PPIases.
Targeting of residues in RopA for mutagenesis was assisted
by the fact that the PPIase domain of trigger factor displays a
high level of homology to other members of the FK506-inhib-
ited PPIase family (16) (Fig. 1B) and that mutation of several
residues in trigger factor that are conserved among FK506-
binding proteins resulted in altered catalytic activity with no
effect on its ability to refold certain proteins in vitro (39). In
addition, the three-dimensional structures for several FK506
type PPIases in complex with FK506 have been determined.
Since FK506 inhibits PPIase activity by inhibiting the binding
of the substrate polypeptide, it is likely that residues important
for binding FK506 will also make contact with the substrate
polypeptide and that the loss of these contacts will lead to a
loss of PPIase activity. An examination of the structure of
FKBP12 (7, 40) identified several residues that make specific
contacts with FK506 (Fig. 1A) that are similar in trigger factor
(Fig. 1B). Three residues in the S. pyogenes trigger factor (D180,
F200, and F235; Fig. 1B) were changed to alanine residues in
order to minimize alteration of the overall conformation of the
FIG. 1. Mutagenesis of RopA. (A) Structure of FKBP12 in com-
plex with FK506. The highlighted residues D180, F200, and F235 make
contact with FK506 and are conserved in the PPIase domain of trigger
factor. The labels represent the residue of FKBP12 and the numbers of
the conserved residues in RopA. The model shown was based on
published structures (7, 40) using the molecular renderer RasMol,
version 2.6 (http://www.umass.edu/microbiol/rasmol/). (B) Domain
structure of trigger factor. The locations of the PPIase domain and
residues (F170, G172, F179, D180, F196, I197, F200, Y223, and F235)
highly conserved between trigger factor and other FK506-binding pro-
teins are indicated. The residues named correspond to those indicated
in panel A and were targeted for mutagenesis. Note that D180 and
F235 are identical between trigger factor and FKBP12 and that F200
of trigger factor corresponds to W200 of FKBP12.
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mutant protein. Purification and analysis of the proteins re-
vealed that each mutation led to a profound decrease in PPIase
activity to between 18 and 7% of the activity the wild-type
protein (compare RopAD180A, RopAF200A, and RopAF235A to
the wild type in Fig. 2).
Characterization of trigger factor mutants. Each of the
three mutations was recreated in a version of the trigger factor
gene that lacked the coding sequence for the six-His affinity
tag, and the mutant alleles were then used to replace the
wild-type ropA allele in the chromosome of S. pyogenes HSC5.
The streptococcal cysteine protease is expressed when the bac-
terial cells enter the stationary phase of growth, and it is se-
creted as an inactive 40-kDa precursor protein. In S. pyogenes
HSC5, the secreted protease remains as the precursor for
about 1 to 2 h after the culture reaches stationary phase and
then is rapidly processed to the mature active 28-kDa protease
(26). Examination of the resulting mutant strains revealed that
each expressed wild-type levels of the precursor protease pro-
tein and that the protease was expressed in a temporal pattern
equivalent to that for the wild type, indicating that the muta-
tions did not disrupt transcriptional regulation of the protease
gene or the trigger factor-dependent targeting activity required
for secretion of the protease (data for RopAF200A are shown in
Fig. 3). However, when the ability of the precursor to become
processed to the 28-kDa mature form of the protease was
analyzed, it was found that the protease produced by each of
the PPIase-defective trigger factor mutants demonstrated the
same kinetic defect in autoprocessing that was observed for the
previously characterized mutant protein with the large internal
ropA deletion (RopA82-297) (26). A characteristic of this de-
fect is that conversion to the 28-kDa mature form takes ap-
proximately 8 h longer than it does for the protease produced
by the wild-type strain (Fig. 3, compare RopAF200A to the wild
type at 10 and 24 h). A second characteristic is that the pro-
cessed protease demonstrates only a fraction of the proteolytic
activity of the wild-type protease (26). Comparison of proteo-
lytic activities at a point where both wild-type and mutant
proteases are fully converted to the mature form (24-h incu-
bation; see Materials and Methods) reveals that each of the
three PPIase-deficient mutants exhibited reduced proteo-
lytic activity (Fig. 2; compare RopAD180A, RopAF200A, and
RopAF235A to the wild type). The decreased level of expression
closely correlated with the levels to which PPIase activity was
decreased for the three mutants and approached that observed
for the original deletion mutant (RopA82-297; Fig. 2).
Identification of a target proline residue. A requirement for
PPIase activity in the production of an active protease implies
that the protease polypeptide possesses at least one proline
residue whose state of isomerization directs subsequent mat-
uration into either a productive or a nonproductive pathway.
Examination of the protease shows that it has 13 prolyl resi-
dues, including 1 in the signal sequence, 1 in the prodomain,
FIG. 2. Protease maturation is defective in the absence of PPIase
activity. The PPIase activity of the indicated site-specific mutant RopA
proteins was compared to that of the wild type following purification of
the six-His-tagged fusion proteins from E. coli. The mutant alleles
lacking the regions encoding the six-His tags were used to replace the
wild-type allele in single copy in the streptococcal chromosome, and
the ability of the resulting strains to express proteolytic activity was
compared to that of the wild type and a trigger factor mutant that
contains ropA with a large in-frame deletion that includes the coding
sequence for the PPIase domain (ropA82-297). Data represent the
means and standard errors of the means for at least two independent
experiments, each of which was conducted in triplicate. NT, not tested.
FIG. 3. Maturation kinetics of SpeB is restored in a ropAF200A mutant through a speBP78G allelic replacement. SpeB was detected in a Western
blot analysis using a SpeB-specific antiserum. The secreted SpeB zymogen (proSpeB) is 40 kDa, while the processed form is 28 kDa. Time points
represent the incubation times of the culture prior to sample harvesting. Similar results were observed for the ropAD180A and ropAF235A alleles (data
not shown). WT, wild type.
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and 11 in the mature polypeptide. Of these, the residue in the
prodomain (P78, with position 1 defined as the first residue of
the zymogen) was of particular interest for several reasons.
First, because of its association with the translating ribosome,
trigger factor may first interact with the amino terminus of the
nascent polypeptide as it exits the ribosome prior to any sub-
sequent folding (23). When analyzed in vitro, trigger factor
preferentially associates with short peptides enriched in basic
and aromatic residues with a positive net charge (28). Use of
the algorithm of Patzelt et al. (28) indicates that a section of
the proregion including P78 (S77 to F89) has a high probability
of being bound by trigger factor. Thus, the prodomain proline
is in a position to interact with trigger factor. Second, the pro-
domains of many cysteine proteases have been shown to func-
tion as intramolecular chaperones and are absolutely required
for proper folding of their proteases (37). Third, the cysteine
protease proregion makes intimate contacts with residues of
the protease active site (6, 20). Thus, it is conceivable that the
structure of the proregion itself could influence the final con-
formation of the active site. To test whether P78 could be a
target of trigger factor, a mutant protease in which P78 was
changed to a glycine residue in order to maximize the flexibility
of the polypeptide at this position was first constructed. When
the speBP78G allele was used to replace the wild-type allele in
S. pyogenes, the resulting mutant secreted the protease poly-
peptide at levels equivalent to those for the wild type and pro-
duced proteolytic activity at a level about 20% reduced from
that of the wild-type strain (Fig. 4; for RopAWT, compare
SpeBWT to SpeBP78G). This indicates that, while P78 is re-
quired for full expression of proteolytic activity, it is not essen-
tial for maturation of the zymogen to an enzyme with activity
for this substrate (casein). In the presence of a PPIase-defi-
cient ropA allele, expression of the wild-type protease gene
results in only about 10% of the proteolytic activity obtained
with the wild-type ropA background (Fig. 4; for SpeBWT, com-
pare RopAWT to RopA82-297). However, when the P78G pro-
tease allele was expressed in a trigger factor PPIase-deficient
background, proteolytic activity increased over that obtained
with the wild-type protease allele in this background (Fig. 4;
for RopA82-297, compare SpeBWT to SpeBP78G) to levels
equivalent to that for the P78G protease in a wild-type trigger
factor background (Fig. 4; for SpeBP78G, compare RopAWT
to RopA82-297). Identical results were obtained when SpeBP78G
was introduced into hosts expressing each of the three ropA
alanine substitution alleles (data not shown). Thus, the P78G
mutation makes the protease maturation step independent of
the requirement for PPIase activity. The ability of the P78G
mutation to suppress PPIase deficiency supports a model in
which trigger factor-promoted isomerization of P78 is required
for directing the maturation of the secreted protease into a
productive pathway.
DISCUSSION
Trigger factor is found in virtually all species of bacteria and
is the only PPIase of Mycoplasma genitalium, the bacterium
that possess the smallest known genome of any freely self-
replicating organism (2). Evidence suggests that trigger factor
in M. genitalium is essential for viability (19). It is present in
pathogenic bacterial species such as the streptococci, and in
E. coli it provides an essential activity that overlaps with that of
DnaK (8, 38). These data imply that trigger factor is essential
for the ability of bacteria to survive in their natural environ-
ments. However, since trigger factor mutants generally have no
obvious defect for growth or for expression of any protein
under laboratory conditions, the function of trigger factor is
not understood.
In the present study, we have shown that the PPIase activity
of trigger factor is required for the maturation of the protease
of S. pyogenes following its secretion from the bacterium. Fur-
thermore, the observation that the mutation of a specific pro-
line residue results in a bypass of the requirement for trigger
factor in protease maturation implies that this residue is the
target of trigger factor’s PPIase activity. When combined with
the known properties of trigger factor, the trigger factor cycle
(23), and our previous observation that trigger factor is also
required for targeting the protease to the streptococcal secre-
tion pathway, these data support the following model. During
translation of the protease message, trigger factor binds to the
N-terminal proregion of the nascent protease polypeptide as it
emerges from the translating ribosome. This interaction is es-
sential for stabilizing the preproprotease in a secretion-com-
petent conformation, and the complex is targeted to the Sec
pathway translocon for secretion across the cellular mem-
brane. During this targeting phase, the PPIase domain of trig-
ger factor introduces information into the nascent protease
polypeptide through isomerization of the proregion proline
residue at position 78. Trigger factor dissociates from the pro-
tease polypeptide as it transits through the Sec translocon and
is recycled into a cytoplasmic pool for reassociation with a
ribosome. The nascent protease polypeptide is now in an ex-
tracellular space, and it folds into its zymogen form via a
folding pathway that is influenced by the isomerization state of
P78.
A key feature of the model is that it predicts that the con-
FIG. 4. Mutation of P78 of the cysteine protease suppresses the
requirement for PPIase activity. A site-specific mutation in the single
chromosomally encoded copy of the protease gene was constructed to
change the prodomain P78 to G in S. pyogenes hosts containing either
wild-type trigger factor (ropA) or trigger factor defective in PPIase
activity (ropA82-297). Protease activity of the resulting strains was com-
pared to that of the wild type (WT). Data represent the means and
standard errors of the means for at least two independent experiments,
each of which was conducted in triplicate.
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formation of the proregion is influenced by the isomerization
state of P78, which in turn provides steric information that
influences the subsequent folding pathway. This idea is consis-
tent with what is known concerning the roles of some prore-
gions in the biogenesis of their cognate proteases. For exam-
ple, the proregions of many proteases, including some cysteine
proteases (37), are essential for the proper folding and activa-
tion of the proteases. When the serine protease subtilisin is
folded in the absence of its prodomain, it can obtain a stable
but inactive molten globule-like intermediate state that can be
converted to an active enzyme upon addition of the prodomain
(32–34). Mutation of single amino acid residues in the subtili-
sin proregion can produce an altered enzymatic conforma-
tion of the activated protease compared to the wild type, even
though the mutant and wild-type enzymes retain identical
amino acid sequences. These data have been interpreted to
suggest that the proregion provides a folding template for
configuration of the active-site residues. Thus, the final state of
the protein is not necessarily that dictated by a global free-
energy minimum directed by the primary amino acid sequence
but rather is one of an ensemble of low-energy minima whose
accessibility is influenced by the conformation of the prore-
gion. Since the subtilisin proregion does not become part of
the final structure, it has been referred to as an intramolecular
chaperone.
The unique aspect of the present study is that, unlike pre-
vious mutational studies that have altered the proregion se-
quence (34), different protease conformations were derived
from interactions with proregions of identical sequences. The
only difference was the presence or absence of PPIase activity
in trigger factor, an accessory protein required for targeting the
protease to the secretory pathway. The streptococcal cysteine
protease is a member of the papain-like cysteine protease
family, and, while the proregions of family members are di-
verse in regards to sequence and length, they can be divided
into two major subfamilies based on structural similarities to
cathepsin L or to cathepsin B. It is not uncommon for members
of both subfamilies to have a proline residue approximately 15
to 20 residues from the carboxy terminus of the proregion, as
for cathepsin B and cathepsin L (P49 and P83, respectively (6,
27). The three-dimensional structures of the two subfamily
prototypes, procathepsin B and procathepsin L, revealed that
their proregions have several common structural features, in-
cluding proregions that loop through the entire substrate bind-
ing groove in the opposite direction to that of the substrate and
proregion prolines that are positioned in the immediate vicin-
ity of the cysteine and histidine residues that comprise the
catalytic machinery (6). The location of the proline residue
suggests that its configuration could influence active-site con-
formation.
The recently determined three-dimensional structure of the
streptococcal protease zymogen revealed that, while the pro-
tease has the canonical papain family structure, the proregion
adopts a unique structure which itself surrounds a substantial
hydrophobic core (20). The latter feature implies that the pro-
region can fold independently into a stable structure. Further-
more, instead of the extended loop structure used by other
cysteine protease zymogens to inhibit proteolytic activity, the
proregion of the streptococcal zymogen inserts an alpha-heli-
cal region into the active-site cleft so that it displaces the
catalytic His (H195) from the active site to prevent any inter-
action of this residue with the catalytic Cys (C47). Activation of
the streptococcal protease apparently involves removal of the
proregion loop and a substantial reorganization of the active
site, including a rotation of H195 into the active site. The fact
that the proregion actively interacts with residues in the active
site, combined with its apparent stability, suggests that the
structure of the proregion could directly influence the final
conformation of the active site. Exactly how P78 could partic-
ipate in this process is less clear. Unlike what is found in many
other cysteine proteases, this Pro residue does not enter the
active-site cleft. In addition, in the recently determined struc-
ture P78 is in the trans conformation. However, it remains to
be determined whether this is the native state of isomerization
for this residue for several reasons, among which are that the
structure was derived from a mutant protease with the catalytic
Cys residue replaced and that the protease was expressed and
purified from E. coli, a process that is notorious for producing
a streptococcal protease with low specific activity.
Problems associated with production of the streptococcal
protease in the gram-negative bacterium E. coli illustrate some
interesting contrasts with the problem of protein secretion in
gram-positive bacteria. While the processes look similar at first
glance and involve many of the same pathways and accessory
proteins such as trigger factor, there are some fundamental
differences. For example, proteins that are secreted by the
general secretory pathway in gram-negative bacteria translo-
cate across the cellular membrane in an unfolded conforma-
tion and are released into the periplasmic space. They then
fold into their final conformations in a controlled environment
rich in folding catalysts including specific chaperones, thiol-
disulfide oxioreductases, and multiple PPIases. In contrast,
gram-positive bacteria lack a clearly defined periplasmic space,
few extracellular folding catalysts have been identified, and it is
unknown whether the organization of their outer surfaces pro-
vides any type of protected environment to facilitate folding.
Thus, the mechanisms by which gram-positive bacteria fold
secreted proteins are unclear.
Also unclear is why the PPIase activity of trigger factor is
required for maturation of the secreted streptococcal protease.
Replacement of P78, the apparent target of the PPIase activity,
has an effect on the ability of the protease precursor to form an
active protease; however, the mutant protease retains substan-
tial activity. The fact that a proline residue has been conserved
at this position implies that its role in protease biogenesis is
more substantial than was revealed by these studies. It is pos-
sible that the in vitro conditions used for folding and analyses
of proteolytic activity do not reflect the conditions that S. pyo-
genes encounters during infection. Also, it is possible that the
casein substrate used to assess proteolytic activity was more
permissive than the native substrate(s), which has not been
identified. Further studies on the folding of this protease and
the role of accessory factors such as trigger factor will be
important for understanding the function of this protease in
infection and the process of protein folding in gram-positive
bacteria.
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